BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22095217)

  • 1. A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.
    Guo Z; Wu C; Wang X; Wang C; Zhang R; Shan B
    Int J Cancer; 2012 Sep; 131(6):1318-22. PubMed ID: 22095217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer.
    Wang C; Guo Z; Wu C; Li Y; Kang S
    Cancer Genet; 2012; 205(7-8):373-6. PubMed ID: 22867998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
    Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
    Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polymorphism at the miR-502 binding site in the 3' untranslated region of SET8 gene is associated with the risk of clear cell renal cell carcinoma].
    Xu JS; Bai YL; Zhang JX; Cui LW; Zhang HR; Zhang SL
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):476-80. PubMed ID: 27346408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer.
    Ding C; Li R; Peng J; Li S; Guo Z
    Exp Ther Med; 2012 Apr; 3(4):689-692. PubMed ID: 22969952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of microRNA 502 binding site SNP in the 3'-untranslated region of the SET8 gene in patients with non-Hodgkin's lymphoma.
    Diao L; Su H; Wei G; Li T; Gao Y; Zhao G; Guo Z
    Tumori; 2014; 100(5):553-8. PubMed ID: 25343552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population.
    Yang S; Guo H; Wei B; Zhu S; Cai Y; Jiang P; Tang J
    Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):149-54. PubMed ID: 24374662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SNP rs16917496 within SET8 3'UTR is associated with the age of onset of breast cancer].
    Zhang BL; Song FJ; Zheng H; Zhang LN; Zhao YR; Chen KX
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):835-7. PubMed ID: 23291132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.
    Xu J; Yin Z; Gao W; Liu L; Yin Y; Liu P; Shu Y
    PLoS One; 2013; 8(10):e77024. PubMed ID: 24146953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma.
    Wang C; Wu J; Zhao Y; Guo Z
    Sci Rep; 2016 Sep; 6():32921. PubMed ID: 27605386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and the TP53 codon 72 polymorphism with cervical cancer in the Chinese population.
    Yang SD; Cai YL; Jiang P; Li W; Tang JX
    Asian Pac J Cancer Prev; 2014; 15(16):6505-10. PubMed ID: 25169478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma.
    Gao Y; He Y; Ding J; Wu K; Hu B; Liu Y; Wu Y; Guo B; Shen Y; Landi D; Landi S; Zhou Y; Liu H
    Carcinogenesis; 2009 Dec; 30(12):2064-9. PubMed ID: 19917630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival.
    Yang B; Liu C; Diao L; Wang C; Guo Z
    Cancer Genet; 2014 Apr; 207(4):141-6. PubMed ID: 24831772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-502/SET8 regulatory circuit in pathobiology of breast cancer.
    Liu B; Zhang X; Song F; Zheng H; Zhao Y; Li H; Zhang L; Yang M; Zhang W; Chen K
    Cancer Lett; 2016 Jul; 376(2):259-67. PubMed ID: 27080302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of an miR-502-binding site polymorphism in the 3'-untranslated region of
    Liu S; Dong H; Wu J; Wang C
    Oncol Lett; 2019 Apr; 17(4):3960-3964. PubMed ID: 30881512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional single nucleotide polymorphism of SET8 is prognostic for breast cancer.
    Liu B; Zhang X; Song F; Liu Q; Dai H; Zheng H; Cui P; Zhang L; Zhang W; Chen K
    Oncotarget; 2016 Jun; 7(23):34277-87. PubMed ID: 27144429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-502-mediated histone methyltransferase
    Zhang S; Guo Z; Xu J; Wang J; Zhang J; Cui L; Zhang H; Liu Y; Bai Y
    Oncol Lett; 2017 Dec; 14(6):7131-7138. PubMed ID: 29250163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population.
    Narouie B; Ziaee SAM; Basiri A; Hashemi M
    Gene; 2017 Aug; 626():354-357. PubMed ID: 28578017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of correlation between genetic variants in three microRNA genes (hsa-miR-146a, hsa-miR-502 binding site, hsa-miR-27a) and breast cancer risk.
    Parchami Barjui S; Reiisi S; Ebrahimi SO; Shekari B
    Curr Res Transl Med; 2017 Nov; 65(4):141-147. PubMed ID: 29128203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.